Publications by authors named "Peter Angelberger"

Claim this Profile
V
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
Margarida Rodrigues, Tatjana Traub-Weidinger, Maria Leimer, Shuren Li, Fritz Andreae, Peter Angelberger

Eur J Nucl Med Mol Imaging· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Alexander Becherer, Monica Szabó, Georgios Karanikas, Patrick Wunderbaldinger, Peter Angelberger

J Nucl Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The labelling of Nanocoll with [111In] for dual-isotope scanning.
Markus Mitterhauser, Wolfgang Wadsak, Leonhard-Key Mien, Harald Eidherr, Sebastian Roka, Peter Angelberger

Appl Radiat Isot· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils.
Shuren Li, Robert Dudczak, Elisabeth Koller, Mehrdad Baghestanian, Minoo Ghannadan, Peter Angelberger

Eur J Clin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Shuren Li, Amir Kurtaran, Mei Li, Tatjana Traub-Weidinger, Oskar Kienast, Peter Angelberger

Eur J Nucl Med Mol Imaging· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis